ARTELO BIOSCIENCES, INC. Cash and Cash Equivalents
ARTELO BIOSCIENCES, INC. (ARTL) had Cash and Cash Equivalents of $4.20 million as of 2026-03-31, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.20M; Cash and Cash Equivalents, at Carrying Value as first filed $10.27M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $600.00K.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $2.64M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $5.72M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-03-31 | $4.20M 10-Q · filed 2026-08-12 | $10.27M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $600.00K 8-K · filed 2026-03-17 | |
| 2023-09-30 | $2.64M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.72M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $6.92M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $6.89M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $7.14M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $12.12M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $10.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.16M 10-K · filed 2023-03-31 | |
| 2021-11-30 | $14.05M 10-Q · filed 2022-01-12 | |
| 2021-08-31 | $6.63M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $6.31M 10-Q · filed 2022-08-09 | |
| 2021-05-31 | $10.05M 10-Q · filed 2021-07-12 | |
| 2021-03-31 | $8.01M 10-Q · filed 2022-05-12 | |
| 2021-02-28 | $10.71M 10-Q · filed 2021-04-13 | |
| 2020-12-31 | $5.78M 10-Q · filed 2022-08-09 | |
| 2020-11-30 | $7.39M 10-Q · filed 2022-01-12 | $7.39M 10-Q · filed 2021-01-14 |
| 2020-08-31 | $2.14M 10-KT · filed 2022-03-21 | $2.14M 10-K · filed 2020-11-04 |
| 2020-05-31 | $1.28M 10-Q · filed 2021-07-12 | |
| 2020-02-29 | $1.98M 10-Q · filed 2021-04-13 | |
| 2019-11-30 | $3.37M 10-Q · filed 2021-01-14 | |
| 2019-08-31 | $4.42M 10-KT · filed 2022-03-21 | $4.42M 10-K · filed 2019-11-25 |
| 2019-05-31 | $286.44K 10-Q · filed 2020-07-13 | |
| 2019-02-28 | $457.33K 10-Q · filed 2020-04-13 | |
| 2018-11-30 | $115.07K 10-Q · filed 2020-01-14 | |
| 2018-08-31 | $337.42K 10-K · filed 2020-11-04 | |
| 2018-05-31 | $326.02K 10-Q · filed 2019-07-15 | |
| 2018-02-28 | $525.11K 10-Q · filed 2019-04-15 | |
| 2017-11-30 | $412.44K 10-Q · filed 2019-01-14 | |
| 2017-08-31 | $572.77K 10-K/A · filed 2019-12-18 | |
| 2017-05-31 | $227.84K 10-Q · filed 2018-07-13 | |
| 2017-02-28 | $10.90K 10-Q/A · filed 2018-05-14 | |
| 2016-11-30 | $3.59K 10-Q/A · filed 2018-03-21 | |
| 2016-08-31 | $3.59K 10-K · filed 2018-11-29 | |
| 2016-05-31 | $3.59K 10-Q · filed 2017-07-21 | |
| 2016-02-29 | $3.59K 10-Q · filed 2017-04-14 | |
| 2015-11-30 | $3.97K 10-Q · filed 2017-01-10 | |
| 2015-08-31 | $17.03K 10-K · filed 2017-11-29 | |
| 2015-05-31 | $12.58K 10-Q · filed 2016-07-05 | |
| 2015-02-28 | $8.08K 10-Q · filed 2016-04-01 | |
| 2014-11-30 | $14.23K 10-Q · filed 2016-01-14 | |
| 2014-08-31 | $14.73K 10-K · filed 2016-11-29 | |
| 2014-05-31 | $15.26K 10-Q · filed 2015-07-15 | |
| 2014-02-28 | $29.91K 10-Q · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |